Screening and Structural Characterization of α-Glucosidase Inhibitors from Hawthorn Leaf Flavonoids Extract by Ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS

Journal of the American Society for Mass Spectrometry

Volumn 20, Issue 8, 2009, Pages 1496-1503

  Li, Huilin ^a,c   Song, Fengrui ^a   Xing, Junpeng ^a   Tsao, Rong ^b   Liu, Zhiqiang ^a   Liu, Shuying ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONES; COLLISION-INDUCED DISSOCIATION; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; FLAVONOIDS; FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY; FT-ICR MS; GLUCOSIDASE; GLYCOSYLATIONS; HIGH RESOLUTION; IN-VITRO; IN-VITRO ASSAYS; INHIBITION ACTIVITY; INHIBITION ASSAYS; INHIBITORY ACTIVITY; ISOVITEXIN; OFF-RESONANCE IRRADIATION; PHOTODIODE ARRAY DETECTIONS; SORI-CID; STRUCTURAL CHARACTERIZATION;

CHROMATOGRAPHIC ANALYSIS; ELECTROSPRAY IONIZATION; ENZYME ACTIVITY; FATTY ACIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; PHENOLS; RESONANCE; ULTRAFILTRATION;

ENZYME INHIBITION;

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; APIGENIN; FLAVONOID; ISOORIENTIN; ISOVITEXIN; LUTEOLIN; ORIENTIN; QUERCETIN 3 O RHAMNOSYL(1-4)GLYCOSYLRHAMNOSIDE; UNCLASSIFIED DRUG; VITEXIN; VITEXIN 2'' O GLUCOSIDE; VITEXIN 2'' RHAMNOSIDE;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CRATAEGUS; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; IN VITRO STUDY; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PLANT LEAF; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALPHA-GLUCOSIDASES; CHROMATOGRAPHY, LIQUID; CRATAEGUS; MASS SPECTROMETRY; PLANT EXTRACTS; PLANT LEAVES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; ULTRAFILTRATION;

CRATAEGUS;

EID: 67650720890     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2009.04.003     Document Type: Article

References (35)

1. Bischoff H. Mechanism of α-Glucosidase Inhibition in the Management of Diabetes. Clin. Invest. Med. 18 (1995) 303-311
2. Coniff R.F., Shapiro J.A., Seaton T.B., and Bray G.A. Multicenter Placebo-Controlled Trial Comparing Acarbose (BAYg5421) with Placebo, Tolbutamide, and Tolbutamide-Plus-Acarbose in Noninsulin-Dependent Diabetes mellitus. Am. J Med. 98 (1995) 443-451
3. Chen J., Cheng Y.Q., Yamaki K., and Li L.T. Anti-α-Glucosidase Activity of Chinese Traditionally Fermented Soybean (douchi). Food Chem. 103 (2007) 1091-1096
4. Gu J.P., and Liang X.M. Study on Inhibition of the Chinese Herbal Medicines on α-Glucosidase. J. Chin. Modern Traditional Chin. Med. 1 (2005) 116-118
5. Gao X.P., Zhang W.Y., Zou W.J., Su Z., Ji Y.Q., and Liu Z.R. Screening for α-Glucosidase Inhibitors from Extracts of Traditional Chinese Medicine. Nat. Prod. Res. Dev. 15 (2005) 536-538
6. Havsteen B. Flavonoids, a Class of Natural Products of High Pharmacological Potency. Biochem. Pharmacol. 32 (1983) 1141-1148
7. McCune L.M., and Johns T. Antioxidant Activity in Medicinal Plants Associated with the Symptoms of Diabetes mellitus Used by the Indigenous Peoples of the North American Boreal Forest. J Ethnopharmacol. 82 (2002) 197-205
8. Lee D.S., and Lee S.H. Genistein, a Soy Isoflavone, is a Potent K-Glucosidase Inhibitor. FEBS Lett. 501 (2001) 84-86
9. Waltner-Law M.E., Wang X.H., Law B.K., Hall R.K., Nawano M., and Granner D.K. Epigallocatechin gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production. J. Biol. Chem. 277 (2002) 34933-34940
10. Quan J.S., Tanaka M., and Kanazawa T. Inhibitory Effect of Soybean Isoflavones on Platelet Aggregation. J. Med. Science (Yanbian University) 25 (2002) 94-96
11. Matsuda H., Morikawa T., Toguchida I., and Yoshikawa M. Structural Requirements of Flavonoids and Related Compounds for Aldose Reductase Inhibitory Activity. Chem. Pharm. Bull. 50 (2002) 788-795
12. Zhao Y.P., Wang C.X., and Du L.X. Study on Chemical Constituents in Fruits and Leaves of Crataegus L. Beverage Industry 6 (2002) 8-12
13. Rigelsky J.M., and Sweet B.V. Hawthorn: Pharmacology and Therapeutic Uses. Am. J. Health Syst. Pharm. 59 (2002) 417-422
14. Knekt P., Kumpulainen J., Järvinen R., Rissanen H., Heliövaara M., Reunanen A., Hakulinen T., and Aromaa A. Flavonoid Intake and Risk of Chronic Diseases. Am. J. Clin. Nutr. 76 (2002) 560-568
15. Shibano M., Kakutani K., Taniguchi M., Yasuda M., and Baba K. Antioxidant Constituents in the Dayflower (Commelina communis L.) and Their α-Glucosidase-Inhibitory Activity. J. Nat. Med. 62 (2008) 349-353
16. Jiang A.L., Liu R.H., Shao F., Ma Z.L., and Yu B.Y. Determination of the Principal Polyphenolic Components in the Leaves of Crataegus L. by LC-MS. Acta Acad. Med. CPAPF 16 (2007) 533-537
17. Ma G., Jiang X.H., Huang T., Liu F., Wang Z.G., and Chen Z. Simultaneous Determination of Five Major Components in Hawthorn Leaves Extract by HPLC. West Chin. J. Pharmaceut. Sci. 22 (2007) 547-549
18. Wu X.A., and Zhao Y.M. Review on C-Glycosylflavone and Its Pharmacology Activities. Pharm. J. Chin. PLA. 21 2 (2005) 135-138
19. Fan C.L., Yan J., Qian Y., Wo X.D., and Gao L.P. Regulation of LPL Expression by Effect of Hawthorn Flavonoids on Peroxisome Proliferator Response Elements Pathway. J. Pharmacol. Sci. 100 (2006) 51-58
20. Rigelsky J.M., and Sweet B.V. Hawthorn: Pharmacology and Therapeutic Uses. Am. J. Health Syst. Pharm. 59 (2002) 417-422
21. Wansi J.D., Lallemand M.C., Chiozem D.D., and Aristide A.F. α-Glucosidase Inhibitory Constituents from Stem Bark of Terminalia superba (Combretaceae). Phytochemistry 68 (2007) 2096-2100
22. Gao H., Huang Y.N., Gao B., Xu P.Y., Chika I., and Jun K. α-Glucosidase Inhibitory Effect by the Flower Buds of Tussilago farfara L. Food Chem. 106 (2008) 1195-1201
23. Xu Z., Yao S.J., Wei Y.L., Zhou J., Zhang L., Wang C.H., and Guo Y.L. Monitoring Enzyme Reaction and Screening of Inhibitors of Acetylcholinesterase by Quantitative Matrix-Assisted Laser Desorption/Ionization Fourier Transform Mass Spectrometry. J. Am. Soc. Mass Spectrom. 19 (2008) 1849-1855
24. Cancilla M.T., Leavell M.D., Chow J., and Leary J.A. Mass Spectrometry and Immobilized Enzymes for the Screening of Inhibitor Libraries. PNAS 97 22 (2000) 12008-12013
25. Chan N.W.C., Lewis D.F., Rosner P.J., Kelly M.A., and Schriemer D.C. Frontal Affinity Chromatography-Mass Spectrometry Assay Technology for Multiple Stages of Drug Discovery: Applications of a Chromatographic Biosensor. Anal. Biochem. 319 (2003) 1-12
26. Dunayevskiy Y.M., Lai J.-J., Quinn C., and Talley F. Vouros, P. Mass Spectrometric Identification of Ligands Selected from Combinatorial Libraries Using Gel Filtration. Rapid Commun. Mass Spectrom. 11 (1997) 1178-1184
27. Chu Y.H., Dunayevskiy Y.M., Kirby D.P., Vouros P., and Karger B.L. Affinity Capillary Electrophoresis-Mass Spectrometry for Screening Combinatorial Libraries. J. Am. Chem. Soc. 118 (1996) 7827-7835
28. Johnson B.M., Nikolic D., and van Breemen R.B. Applications of Pulsed Ultrafiltration-Mass Spectrometry. Mass Spectrom. Rev. 21 (2002) 76-86
29. Sun Y.K., Gu C.G., Liu X.M., Liang W.Z., Yao P., Bolton J.L., and van Breemen R.B. Ultrafiltration Tandem Mass Spectrometry of Estrogens for Characterization of Structure and Affinity for Human Estrogen Receptors. J. Am. Soc. Mass Spectrom. 16 (2005) 271-279
30. Liu D.T., Guo J., Luo Y., Broderick D.J., Schimerlik M.I., Pezzuto J.M., and van Breemen R.B. Screening for Ligands of Human Retinoid X Receptor-r Using Ultrafiltration Mass Spectrometry. Anal. Chem. 79 (2007) 9398-9402
31. Li T., Zhang X.D., Song Y.W., and Liu J.W. A Microplate-Based Screening Method for α-Glucosidase Inhibitors. Nat. Prod. Res. Dev. 10 (2005) 1128-1134
32. Ablajan K., Abliz Z., Shang X.Y., He J.M., Zhang R.P., and Shi J.G. Structural Characterization of Flavonol 3,7-di-O-Glycosides and Determination of the Glycosylation Position by Using Negative Ion Electrospray Ionization Tandem Mass Spectrometry. J. Mass Spectrom. 41 (2006) 352-360
33. Tadera K., Minami Y., Takamatsu K., and Matsuoka T. Inhibition of α-Glucosidase and α-Amylase by Flavonoids. J. Nutr. Sci. Vitaminol. 52 (2006) 149-153
34. Gao H., Nishioka T., Kawabata J., and Kasai T. Structure-Activity Relationships for α-Glucosidase Inhibition of Baicalein, 5,6,7-Trihydroxyflavone: The Effect of A-Ring Substitution. Biosci. Biotechnol. Biochem. 68 (2004) 369-375
35. Matsuda H., Morikawa T., Toguchida I., and Yoshikawa M. Structural Requirements of Flavonoids and Related Compounds for Aldose Reductase Inhibitory Activity. Chem. Pharm. Bull. 50 6 (2002) 788-795